- High Plasma Levels of the B-type Natriuretic Peptide in Patients Without Heart Failure: Is There Clinical Significance?
-
Yu LH, Kim MH, Park JS, Cha KS, Park TH, Kim YD
- KMID: 2094075
- Korean Circ J.
- 2010 Mar;40(3):141-142.
- doi: 10.4070/kcj.2010.40.3.141
We report a case of a 19-year-old female with an elevated plasma B-type natriuretic peptide (BNP) level, but without evidence of heart failure (HF). She presented with non-specific chest pain... -
- CITED
-
- Close
- SHARE
-
- Close
- Initial Experience of Retrograde Wire Approach in Coronary Chronic Total Occlusion Intervention
-
Chung SH, Kim MH, Yu LH, Park JS, Kim KH, Kum DS, Park TH, Cha KS, Kim YD
- KMID: 1490698
- Korean Circ J.
- 2009 Jun;39(6):228-235.
- doi: 10.4070/kcj.2009.39.6.228
BACKGROUND AND OBJECTIVES: Retrograde wire approach has been emerged as a useful tool to enhance success rate in coronary chronic total occlusion (CTO) intervention. Therefore, we tried to report the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between the Portable Prothrombin Time Self Monitor CoaguChek XS and a Standard Laboratory Method, Sysmex CA-1500 for Monitoring Anticoagulant Therapy of Outpatients
-
Kim JW, Kim MH, Kim KH, Han J, Paik JH, Yu LH, Park TH, Cha KS, Kim YD, Kim KE, Han JY
- KMID: 2227067
- Korean Circ J.
- 2007 May;37(5):216-220.
- doi: 10.4070/kcj.2007.37.5.216
BACKGROUND AND OBJECTIVES: Patients on oral anticoagulation therapy (OAT) require regular monitoring of the prothrombin time (PT) and dosage adjustment to prevent thromboembolic diseases without the risk of hemorrhage. Portable... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Platelet Function Test on Platelet Responsiveness and Clinical Outcome After Coronary Stent Implantation: Platelet Responsiveness and Clinical Outcome
-
Yu LH, Kim MH, Zhang HZ, Park JS, Park TH, Kim YD, Cha KS, Han JY
- KMID: 1433857
- Korean Circ J.
- 2012 Jun;42(6):382-389.
- doi: 10.4070/kcj.2012.42.6.382
BACKGROUND AND OBJECTIVES: The aim of this study was to confirm the predictive cut-off values for P2Y12 reaction units (PRU) and aspirin reaction units (ARU) and to evaluate the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of the Prevalence of Aspirin and Clopidogrel Resistances in Patients with Coronary Artery Disease by using Various Platelet-function Tests
-
Woo KS, Kim BR, Kim JE, Goh RY, Yu LH, Kim MH, Han JY
- KMID: 1022035
- Korean J Lab Med.
- 2010 Oct;30(5):460-468.
- doi: 10.3343/kjlm.2010.30.5.460
BACKGROUND: Dual therapy with aspirin and clopidogrel has emerged as the gold standard therapy for patients treated with drug-eluting stents (DES). However, there is variability in patients' responses to this... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Effects of Additional Cilostazol Administration After Drug-Eluting Stent Insertion
-
Kum DS, Kim MH, Paik JH, Yu LH, Han J, Kim KH, Park TH, Cha KS, Kim YD, Quan ML, Han JY
- KMID: 1769509
- Korean Circ J.
- 2009 Jan;39(1):21-25.
- doi: 10.4070/kcj.2009.39.1.21
BACKGROUND AND OBJECTIVES: Cilostazol, a selective inhibitor of phosphodiesterase III (PDE III), prevents inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP) and irreversibly inhibits platelet aggregation and vasodilation.... -
- CITED
-
- Close
- SHARE
-
- Close
